New triple-threat treatment tested for tough-to-treat gynecologic cancers

This study is testing whether combining three existing cancer drugs works better than current options for women whose endometrial, ovarian, fallopian tube, or primary peritoneal cancer has returned or stopped responding to platinum chemotherapy. The trial will enroll 38 participants to see if the combination can shrink tumors, control the disease for longer, and is safe enough for patients to tolerate. This is not a cure, but aims to provide a new treatment option for cancers that have few remaining choices.